Company Overview
DIANTHUS THERAPEUTICS, INC. /DE/
DNTHRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
2M
2025 FY
Net Income
-162M
2025 FY
Shares Outstanding
39M
2025 FY
EPS
-4.2USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1690585
Exchange
Nasdaq
Location
US